Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

Similar articles for PubMed (Select 23959874)

1.

Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.

Lanz TV, Becker S, Osswald M, Bittner S, Schuhmann MK, Opitz CA, Gaikwad S, Wiestler B, Litzenburger UM, Sahm F, Ott M, Iwantscheff S, Grabitz C, Mittelbronn M, von Deimling A, Winkler F, Meuth SG, Wick W, Platten M.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14735-40. doi: 10.1073/pnas.1302569110. Epub 2013 Aug 19.

2.

Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.

Wang C, Wang C, Dong H, Wu XM, Wang C, Xia F, Li G, Jia X, He S, Jiang X, Li H, Xu H.

Mol Immunol. 2013 Jan;53(1-2):43-51. doi: 10.1016/j.molimm.2012.06.009. Epub 2012 Jul 13.

PMID:
22796503
3.

The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.

Giacoppo S, Galuppo M, Iori R, De Nicola GR, Bramanti P, Mazzon E.

Eur Rev Med Pharmacol Sci. 2014;18(2):194-204.

4.

Effects of fumaric acid esters on blood-brain barrier tight junction proteins.

Bénardais K, Pul R, Singh V, Skripuletz T, Lee DH, Linker RA, Gudi V, Stangel M.

Neurosci Lett. 2013 Oct 25;555:165-70. doi: 10.1016/j.neulet.2013.09.038. Epub 2013 Sep 26.

PMID:
24076006
5.

Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.

Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, Schaeren-Wiemers N, Deutsch U, Engelhardt B.

Acta Neuropathol. 2011 Nov;122(5):601-14. doi: 10.1007/s00401-011-0883-2. Epub 2011 Oct 9.

6.

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

Göbel K, Pankratz S, Schneider-Hohendorf T, Bittner S, Schuhmann MK, Langer HF, Stoll G, Wiendl H, Kleinschnitz C, Meuth SG.

J Autoimmun. 2011 Mar;36(2):106-14. doi: 10.1016/j.jaut.2010.11.004. Epub 2011 Jan 8.

PMID:
21216565
7.

Inhibition of glycogen synthase kinase 3β promotes tight junction stability in brain endothelial cells by half-life extension of occludin and claudin-5.

Ramirez SH, Fan S, Dykstra H, Rom S, Mercer A, Reichenbach NL, Gofman L, Persidsky Y.

PLoS One. 2013;8(2):e55972. doi: 10.1371/journal.pone.0055972. Epub 2013 Feb 13.

8.

Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z.

PLoS One. 2011;6(8):e20599. doi: 10.1371/journal.pone.0020599. Epub 2011 Aug 17. Erratum in: PLoS One. 2011;6(8). doi: 10.1371/annotation/716c0fb2-dbdd-4da5-ad8a-d2b1cdac4ec6.

9.

Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.

Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, Lou J, Gao Y, Wang S, Wang Y.

J Ethnopharmacol. 2012 Jun 1;141(2):714-20. doi: 10.1016/j.jep.2011.08.063. Epub 2011 Sep 3.

PMID:
21920425
11.

Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.

Bittner S, Ruck T, Schuhmann MK, Herrmann AM, Moha ou Maati H, Bobak N, Göbel K, Langhauser F, Stegner D, Ehling P, Borsotto M, Pape HC, Nieswandt B, Kleinschnitz C, Heurteaux C, Galla HJ, Budde T, Wiendl H, Meuth SG.

Nat Med. 2013 Sep;19(9):1161-5. doi: 10.1038/nm.3303. Epub 2013 Aug 11.

PMID:
23933981
12.

Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.

Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B.

Acta Neuropathol. 2003 Jun;105(6):586-92. Epub 2003 Feb 25.

PMID:
12734665
13.
14.

Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR.

FASEB J. 2010 Apr;24(4):1023-34. doi: 10.1096/fj.09-141978. Epub 2009 Nov 25.

15.

Transient alterations of the blood-brain barrier tight junction and receptor potential channel gene expression by chlorpyrifos.

Li W, Ehrich M.

J Appl Toxicol. 2013 Oct;33(10):1187-91. doi: 10.1002/jat.2762. Epub 2012 May 18.

PMID:
22611033
16.

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.

Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG, Jain P.

J Neuroinflammation. 2012 Oct 26;9:245. doi: 10.1186/1742-2094-9-245.

17.

Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury.

Thal SC, Luh C, Schaible EV, Timaru-Kast R, Hedrich J, Luhmann HJ, Engelhard K, Zehendner CM.

PLoS One. 2012;7(12):e50752. doi: 10.1371/journal.pone.0050752. Epub 2012 Dec 10.

18.

Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Sonobe Y, Takeuchi H, Kataoka K, Li H, Jin S, Mimuro M, Hashizume Y, Sano Y, Kanda T, Mizuno T, Suzumura A.

J Biol Chem. 2009 Nov 13;284(46):31834-42. doi: 10.1074/jbc.M109.025940. Epub 2009 Sep 23.

19.

Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier.

Winger RC, Koblinski JE, Kanda T, Ransohoff RM, Muller WA.

J Immunol. 2014 Sep 1;193(5):2427-37. doi: 10.4049/jimmunol.1400700. Epub 2014 Jul 25.

PMID:
25063869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk